TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7020563

Group type: EXPERIMENTAL
Intervention: Sorghum beer (2 litres, carbohydrate content approximately 5%, alcohol concentration 2.24 g/dl-2.8% v/v)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control solution (2 litres providing a similar carbohydrate load)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Gin and tonic mixture
Number of subjects: 8
Study: 31021140

Group type: EXPERIMENTAL
Intervention: Educational intervention about the harmful impact of gender stereotypes in STEM and strategies for coping with stereotype threat
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 199
Study: 31081522

Group type: EXPERIMENTAL
Intervention: Half-dose ticagrelor (90 mg LD, then 45 mg twice daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: High-dose clopidogrel (150 mg once daily)
Number of subjects: 80
Study: 30036076

Group type: EXPERIMENTAL
Intervention: Methylphenidate extended release (MPH‐MLR)
Number of subjects: 200
Study: 27455854

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (SCIg) IgPro20 at 0.2 g/kg bw
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (SCIg) IgPro20 at 0.4 g/kg bw
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study: 24929795

Group type: EXPERIMENTAL
Intervention: Probinul-neutro®
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 23059741

Group type: EXPERIMENTAL
Intervention: Short axis view combined with out-of-plane needle tip approach (dynamic needle tip positioning)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Long axis view combined with in-plane needle tip approach
Number of subjects: 59
Study: 20528977

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone (IVTA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 27
Study: 18473373

Group type: EXPERIMENTAL
Intervention: Resting QTd in Group 2 (significant CAD)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Adenosine stress QTd in Group 1 (no stenosis)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Adenosine stress QTd in Group 2 (significant CAD)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Resting QTd in patients with significant CAD
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Resting QTd (4th Quartile)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Delta QTd (1st and 2nd Quartiles)
Number of subjects: 88
Study: 15718288

Group type: EXPERIMENTAL
Intervention: Diphenhydramine coadministration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12886207

Group type: EXPERIMENTAL
Intervention: Monophase impression material
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Rigid impression material
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Plastic dual-arch trays with monophase material
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metal dual-arch trays
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sequence of pouring impressions
Number of subjects: 10
Study: 10589403

Group type: EXPERIMENTAL
Intervention: Butoconazole 1-BSR (single dose)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Miconazole 7 (seven-day treatment)
Number of subjects: 205
Study: 8789864

Group type: EXPERIMENTAL
Intervention: Intraoperative extraconal bupivacaine injection
Number of subjects: 40
Study: 1586374

Group type: EXPERIMENTAL
Intervention: Buccal administration of 5 mg ISDN
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oral administration of 5 mg ISDN
Number of subjects: 12
Study: 6086974

Group type: EXPERIMENTAL
Intervention: Cyclic alternating chemotherapy with a four-drug combination of COMP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-drug combination of VP-16, adriamycin and ACNU (VAN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concomitant chest irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation
Number of subjects: 0
Study: 30420184

Group type: EXPERIMENTAL
Intervention: LDS + EZE
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: LDS + ALP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: LDS + EZE + ALP (triple combination)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 100
Study: 29303450

Group type: EXPERIMENTAL
Intervention: Subcutaneous preservation of autologous bone flap
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Cranioplasty with autologous bone
Number of subjects: 193

Group type: COMPARATOR
Intervention: Custom synthetic implant
Number of subjects: 193
Study: 27476886

Group type: EXPERIMENTAL
Intervention: 1:1:1 transfusion ratio of plasma and platelets to red blood cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1:1:2 transfusion ratio of plasma and platelets to red blood cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1:1:1 transfusion ratio
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1:1:2 transfusion ratio
Number of subjects: 0
Study: 24888540

Group type: EXPERIMENTAL
Intervention: Icterometer group (IG)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 352
Study: 22581821

Group type: EXPERIMENTAL
Intervention: Theta burst stimulation over the intact right Broca's homologue
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 18
Study: 20881505

Group type: EXPERIMENTAL
Intervention: Stepwise periodized resistance exercise program with 100 swings a day, 3 days/week for 12 weeks (Group 1)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Stepwise periodized resistance exercise program with additional rotational and full-body medicine ball exercises, 3 days/week for 12 weeks (Group 2)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Stepwise periodized resistance exercise program (Group 1)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Stepwise periodized resistance exercise program with additional exercises (Group 2)
Number of subjects: 49
Study: 19016270

Group type: EXPERIMENTAL
Intervention: Psychologic Intervention plus assessment
Number of subjects: 227

Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 227
Study: 15748122

Group type: EXPERIMENTAL
Intervention: Manual hyperinflation plus suction
Number of subjects: 15

Group type: COMPARATOR
Intervention: Suction alone
Number of subjects: 15
Study: 12091067

Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg/daily orally in three doses plus morphine escalation
Number of subjects: 156

Group type: COMPARATOR
Intervention: Morphine only
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Ketorolac-morphine group
Number of subjects: 156

Group type: COMPARATOR
Intervention: Morphine group
Number of subjects: 156
Study: 10334415

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg twice daily for 4 weeks)
Number of subjects: 10
Study: 8610602

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 43
Study: 8288175

Group type: EXPERIMENTAL
Intervention: 90-day methadone detoxification coupon
Number of subjects: 4390

Group type: COMPARATOR
Intervention: 21-day methadone detoxification coupon
Number of subjects: 4390
Study: 3016134

Group type: EXPERIMENTAL
Intervention: Dopamine (1 microgram/kg per min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30354493

Group type: EXPERIMENTAL
Intervention: Coronary CTA-specific definitions of high-risk plaque features
Number of subjects: 472

Group type: COMPARATOR
Intervention: IVUS definitions
Number of subjects: 472
Study: 27653887

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2mA for four 20-minute sessions)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 21
Study: 25587645

Group type: EXPERIMENTAL
Intervention: 50 mg/d lisdexamfetamine
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: 70 mg/d lisdexamfetamine
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: 30 mg/d lisdexamfetamine
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 24101042

Group type: EXPERIMENTAL
Intervention: Conventional fractionation intensity‐modulated radiation therapy (CIMRT) - 76 Gy in 38 fractions at 2.0 Gy per fraction
Number of subjects: 303

Group type: COMPARATOR
Intervention: Hypofractionated IMRT (HIMRT) - 70.2 Gy in 26 fractions at 2.7 Gy per fraction
Number of subjects: 303
Study: 21744190

Group type: EXPERIMENTAL
Intervention: Application of stickers and criteria for switch to oral antimicrobial therapy to the drug chart in the study group post-intervention
Number of subjects: 85

Group type: COMPARATOR
Intervention: Conventional practice of clinical pharmacists reviewing drug charts and contacting prescribers to discuss a switch to an oral antimicrobial in the control group
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Study group post-intervention
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 85
Study: 19565559

Group type: EXPERIMENTAL
Intervention: Intraarticular infliximab
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intraarticular methylprednisolone
Number of subjects: 23
Study: 16738023

Group type: EXPERIMENTAL
Intervention: External explanation for violation of equality
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of trust in others
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induced high trust with external explanation being a lie
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attribution information
Number of subjects: 0
Study: 15305962

Group type: EXPERIMENTAL
Intervention: Overdrive pacing from coronary sinus and/or posterior right atrium at different cycle lengths (900 to 400 ms; duration: 30 to 60 s)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Isoproterenol administration
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Adenosine administration
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Carotid sinus massage (CSM)
Number of subjects: 15
Study: 11738309

Group type: EXPERIMENTAL
Intervention: Metoprolol (0.1 mg/kg)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Sotalol (1.0 mg/kg)
Number of subjects: 54
Study: 9789898

Group type: EXPERIMENTAL
Intervention: DSS members (Group III)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Patients with symptoms from Group I
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: DSS members
Number of subjects: 448

Group type: COMPARATOR
Intervention: Non-member group
Number of subjects: 448
Study: 7905095

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori eradication treatment (HET)
Number of subjects: 63

Group type: COMPARATOR
Intervention: H pylori positive
Number of subjects: 63

Group type: COMPARATOR
Intervention: H pylori negative
Number of subjects: 63
Study: 2721334

Group type: EXPERIMENTAL
Intervention: Naltrexone 2.0 mg/kg
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 29605395

Group type: EXPERIMENTAL
Intervention: Prophylactic dextrose gel (0.5 mL/kg) rubbed into the buccal mucosa
Number of subjects: 236

Group type: COMPARATOR
Intervention: Control group (feedings alone)
Number of subjects: 236
Study: 27743922

Group type: EXPERIMENTAL
Intervention: Isolated non-peritoneal metastatic colorectal cancer
Number of subjects: 10553

Group type: EXPERIMENTAL
Intervention: Two or more non-peritoneal sites of metastasis
Number of subjects: 10553

Group type: EXPERIMENTAL
Intervention: Peritoneal metastatic colorectal cancer plus one other site of metastasis
Number of subjects: 10553

Group type: EXPERIMENTAL
Intervention: Peritoneal metastases and two or more additional sites of metastasis
Number of subjects: 10553
Study: 24201177

Group type: EXPERIMENTAL
Intervention: Proactive Ethics Intervention
Number of subjects: 384

Group type: COMPARATOR
Intervention: Control
Number of subjects: 384
Study: 23076338

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (26-week multidisciplinary treatment programme)
Number of subjects: 112
Study: 20858829

Group type: EXPERIMENTAL
Intervention: Protocol C (15 HU and 600 mg I/kg)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Protocol A (12 HU and 521 mg I/kg)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Protocols B and C (15 HU and 521 mg I/kg; 15 HU and 600 mg I/kg)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Protocols A and C (12 HU and 521 mg I/kg; 15 HU and 600 mg I/kg)
Number of subjects: 195
Study: 18479175

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Esomeprazole 80 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pantoprazole 80 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Esomeprazole vs Pantoprazole (milligram-per-milligram comparison)
Number of subjects: 0
Study: 15845680

Group type: EXPERIMENTAL
Intervention: Etomidate/Desflurane (ETO/DES)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Target-Controlled Infusion (TCI) of Propofol
Number of subjects: 49

Group type: COMPARATOR
Intervention: Manually Controlled (MAN) Propofol Infusion
Number of subjects: 49
Study: 12887343

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (Emdogain, BIORA AB, Malmo, Sweden) applied subgingivally
Number of subjects: 22

Group type: COMPARATOR
Intervention: No additional treatment (Control)
Number of subjects: 22
Study: 10472324

Group type: EXPERIMENTAL
Intervention: Orchiectomy with Mitomycin C
Number of subjects: 178

Group type: COMPARATOR
Intervention: Orchiectomy alone
Number of subjects: 178
Study: 2239143

Group type: EXPERIMENTAL
Intervention: Controlled-release carbamazepine (CR CBZ)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional carbamazepine (CBZ)
Number of subjects: 48
Study: 402795

Group type: EXPERIMENTAL
Intervention: Thyrotropin-Releasing Hormone (TRH) administered orally, 20 mg three times a day for 3 weeks (double-blind study)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Thyrotropin-Releasing Hormone (TRH) administered orally, 20 mg four times a day for 2 weeks (open controlled study)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Thyrotropin-Releasing Hormone (TRH) administered orally
Number of subjects: 9
Study: 31568199

Group type: EXPERIMENTAL
Intervention: Striving app
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Boning Up e-book
Number of subjects: 290

Group type: COMPARATOR
Intervention: Wait List
Number of subjects: 290
Study: 31026734

Group type: EXPERIMENTAL
Intervention: Stigma (enacted and internalized)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Number of public settings used for drug consumption (shooting gallery, crack house, abandoned building, public bathroom, outside)
Number of subjects: 444
Study: 28234790

Group type: EXPERIMENTAL
Intervention: Levosimendan 0.2 μg/kg/min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dobutamine 5 μg/kg/min
Number of subjects: 20
Study: 26021668

Group type: EXPERIMENTAL
Intervention: Short-term (8-week) intensive online Bone Power program
Number of subjects: 866

Group type: EXPERIMENTAL
Intervention: Longer term (12-month) Bone Power Plus program including a 10-month online booster intervention (biweekly eHealth newsletters)
Number of subjects: 866
Study: 23705624

Group type: EXPERIMENTAL
Intervention: Home-based sampling by mailed test-kit
Number of subjects: 216

Group type: COMPARATOR
Intervention: Clinic-based testing without appointment
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Overall chlamydia positivity rate at retest
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Non-Dutch participants
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Participants reporting symptoms
Number of subjects: 216
Study: 21482966

Group type: EXPERIMENTAL
Intervention: Diesel exhaust inhalation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Particle trap
Number of subjects: 19

Group type: COMPARATOR
Intervention: Filtered air
Number of subjects: 19
Study: 20139575

Group type: EXPERIMENTAL
Intervention: Colgate Herbal toothpaste
Number of subjects: 30

Group type: COMPARATOR
Intervention: Colgate toothpaste (control)
Number of subjects: 30
Study: 17327524

Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 284

Group type: COMPARATOR
Intervention: Present-centered therapy
Number of subjects: 284
Study: 15295221

Group type: EXPERIMENTAL
Intervention: Topical application of sunflower seed oil 3 times daily
Number of subjects: 103

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 103
Study: 11602220

Group type: EXPERIMENTAL
Intervention: Self-Harass
Number of subjects: 42

Group type: COMPARATOR
Intervention: Friend-Harass
Number of subjects: 42
Study: 9640214

Group type: EXPERIMENTAL
Intervention: Breast-Conserving Therapy (BCT)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Modified Radical Mastectomy (MRM)
Number of subjects: 278
Study: 8023354

Group type: EXPERIMENTAL
Intervention: 40-microns arterial line filter
Number of subjects: 100

Group type: COMPARATOR
Intervention: No arterial line filter
Number of subjects: 100
Study: 3181323

Group type: EXPERIMENTAL
Intervention: Live attenuated measles vaccine developed in chick embryo cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Live attenuated measles vaccines developed in human diploid cells (HDC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Live attenuated measles vaccine developed in baby calf kidney cells
Number of subjects: 0
Study: 436923

Group type: EXPERIMENTAL
Intervention: Practolol 4 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Practolol 1 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Propranolol 0.2 mg/kg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31648187

Group type: EXPERIMENTAL
Intervention: 0.5 mg of testosterone
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 31090457

Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve A1 supplementation for 12 weeks
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 28263901

Group type: EXPERIMENTAL
Intervention: High intensity aquatic resistance training (48 sessions over 4 months)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (normal physical activity)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Leisure time physical activity (LTPA)
Number of subjects: 87
Study: 25466317

Group type: EXPERIMENTAL
Intervention: Protocolized sedation only
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Protocolized sedation plus daily interruption (DI)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Daily interruption (DI)
Number of subjects: 31
Study: 23820000

Group type: EXPERIMENTAL
Intervention: Amino acid-based formula (AF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extensively hydrolyzed casein-based formula (HF)
Number of subjects: 0
Study: 22594137

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg twice daily)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (lactose pill twice daily)
Number of subjects: 8
Study: 20190130

Group type: EXPERIMENTAL
Intervention: High genetic risk and exposed to depression
Number of subjects: 1159

Group type: COMPARATOR
Intervention: Low genetic risk and without phenotypic expression of depression
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: Genetic liability without phenotypic expression of depression
Number of subjects: 1159
Study: 18198639

Group type: EXPERIMENTAL
Intervention: Tetramethylpyrazine (TMP) treatment for 14 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 15990619

Group type: EXPERIMENTAL
Intervention: Treatment for ocular hypertension with NNT of 20 for average patients, NNT of 6 for those with IOP > or =26 mm Hg.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Targeting higher risk patients for treatment.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Collaborative initial glaucoma treatment study (CIGTS) justifying primary surgery.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ocular hypertension public health intervention.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: POAG public health intervention.
Number of subjects: 20
Study: 12027853

Group type: EXPERIMENTAL
Intervention: Bicarbonate infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 0
Study: 10073846

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 5000
Study: 8903978

Group type: EXPERIMENTAL
Intervention: Topicaina spray (benzocaine butyl aminobenzoate, amethocaine, butacaine)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study: 1978605

Group type: COMPARATOR
Intervention: saline (group 1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: tubocurarine 0.05 mg/kg (group 2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: vecuronium 0.006 mg/kg (group 3)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: midazolam 0.025 mg/kg (group 4)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: vecuronium 0.1 mg/kg (group 5)
Number of subjects: 100
Study: 298360

Group type: EXPERIMENTAL
Intervention: haloperidol
Number of subjects: 24

Group type: COMPARATOR
Intervention: mesoridazine
Number of subjects: 24
Study: 31804699

Group type: EXPERIMENTAL
Intervention: Carmustine wafer implantation followed by chemoradiotherapy with temozolomide
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard maximal resection followed by chemoradiotherapy with temozolomide
Number of subjects: 250
Study: 28280109

Group type: EXPERIMENTAL
Intervention: Dehydration (2 h of exercise in the heat with no fluid intake)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (2 h of exercise with ad libitum fluid intake)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rest (time-matched rest period)
Number of subjects: 10
Study: 26297883

Group type: EXPERIMENTAL
Intervention: 1% NaF+9% HMP
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2% NaF
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: 1% NaF
Number of subjects: 12
Study: 22888075

Group type: EXPERIMENTAL
Intervention: Combined ADT and RTH
Number of subjects: 60

Group type: COMPARATOR
Intervention: RTH only
Number of subjects: 60